News

Mediphar Labs. has launched MEDISTAN® lozenges in January 2020 in the Lebanese market.

MEDISTAN lozenges are highly effective for the treatment of candidiasis in the oral cavity. It has both fungicidal and fungistatic activity.

We are proud to be introducing this medicament into the market, providing patients with a new lozenge form of MEDISTAN. MEDISTAN Lozenges provides high clinical and mycological cure rate, high patient acceptance and cost effectiveness.

MEDISTAN® lozenges is available in the below dosage

 • Nystatin, 200000 IU, Pack of 30 lozenges